Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2012
08/15/2012CN101653440B Treatment composition containing amlodipine series salt and pril medicament
08/15/2012CN101578284B Agent for improving insulin resistance
08/15/2012CN101570496B Curcumin-4-nitrogen-containing derivatives, and preparation method and uses thereof
08/15/2012CN101511364B Combination treatment for diabetes mellitus
08/15/2012CN101495463B Seven-membered ring compound, production method thereof and pharmaceutical use thereof
08/15/2012CN101366874B Medicament composition for preventing birth defect and improving memory
08/15/2012CN101366803B Medicament composition for preventing birth defect and improving memory
08/15/2012CN101366802B Medicament composition for preventing birth defect and improving memory
08/15/2012CN101307046B Tripeptidyl peptidase inhibitors
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/15/2012CN101062919B 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
08/14/2012US8242281 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
08/14/2012US8242173 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
08/14/2012US8242168 Use of phthalide derivatives for the treatment of type 2 diabetes mellitus
08/14/2012US8242147 Aryl ureas with angiogenisis inhibiting activity
08/14/2012US8242096 Compositions comprising pectin and ascorbic acid
08/14/2012US8241675 Elemental indium and indium compounds suitable for human, mammal, fowl and reptilian nutrition
08/14/2012US8241665 Chewable soft capsule
08/14/2012CA2710182C Pyrimidyl indoline compound
08/14/2012CA2562075C Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
08/14/2012CA2559974C Compositions and methods for reducing or preventing obesity
08/14/2012CA2472021C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/14/2012CA2468302C Compounds for treatment of inflammation, diabetes and related disorders
08/09/2012WO2012106584A2 Pitavastatin salts
08/09/2012WO2012105816A2 Composition for preventing and treating diabetes and diabetes complications comprising amphicarpaea edgeworthii var. trisperma powder or an extract thereof
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012105475A1 Therapeutic or prophylactic agent for cachexia
08/09/2012WO2012105130A1 Fat and oil composition for promoting insulin secretion
08/09/2012WO2012104869A1 Treatment for lipodystrophy
08/09/2012WO2012104846A1 Ras inhibitors for treating diseases or pathological conditions characterized insulin resistance
08/09/2012WO2012104589A1 Weight related disorders
08/09/2012WO2012104569A1 Composition of monoterpenoids for the treatment of cancer
08/09/2012WO2012104467A1 Use of no synthase (nos) activity inhibitors and compositions thereof in the production of a drug for the treatment and prevention of prediabetes and type 1 diabetes mellitus (dm1)
08/09/2012WO2012104342A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012103806A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012WO2012103777A1 Compound isolated from monascus purpureus, preparation method therefor and uses thereof
08/09/2012WO2012103637A1 Functional foods and beverages with synergistic properties to promote homeostasis
08/09/2012WO2012075342A3 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
08/09/2012WO2012047495A3 Methods for preparing synthetic bile acids and compositions comprising the same
08/09/2012WO2011156451A3 Compositions and methods for modulating toll-like receptor 2 activation
08/09/2012WO2011087981A3 Clinical benefits of eicosapentaenoic acid in humans
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120202888 Biomarkers of prostate cancer and predicting mortality
08/09/2012US20120202881 Novel NIDDM Regimen
08/09/2012US20120202870 Treatment of inflammatory diseases using mir-124
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202857 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
08/09/2012US20120202855 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202834 Glucagon receptor modulators
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202820 Pharmaceutical composition having the active substances metformin and sitagliptin or vildagliptin
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202816 Novel compounds
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202806 Novel Pyrimidine- And Triazine-Hepcidine Antagonists
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202803 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/09/2012US20120202796 Method for combating adverse effects arising from antipsychotic treatment
08/09/2012US20120202793 Rho kinase inhibitors
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202783 Fused heterocyclic compounds as orexin receptor modulators
08/09/2012US20120202764 Low molecular weight pharmacological activity modulators
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202759 Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
08/09/2012US20120202756 Use of prodrugs to avoid gi mediated adverse events
08/09/2012US20120202755 Foliamangiferosides, preparation method and use thereof
08/09/2012US20120202747 Pharmaceutical composition, food or drink, and methods related thereto
08/09/2012US20120202739 Gdf3 antibodies and related methods
08/09/2012US20120201885 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201877 Calcium Carbonate Granulation
08/09/2012US20120201875 Stable low digestive enzyme content formulation
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201853 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012CA2837751A1 Functional foods and beverages with synergistic properties to promote homeostasis
08/09/2012CA2828988A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012CA2826178A1 A compound separated from monascus-fermented rice, the preparation method and uses thereof
08/09/2012CA2825456A1 Treatment for lipodystrophy
08/09/2012CA2825165A1 Therapeutic or prophylactic agent for cachexia
08/09/2012CA2825162A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2484692A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484669A1 Novel phenol derivative
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484371A1 Use of Hsp70 as a regulator of enzymatic activity
08/08/2012EP2484370A1 Composition having lipolysis-promoting effect
08/08/2012EP2484369A1 Manufacturing method for dried earthworm powder
08/08/2012EP2484361A1 Agent for reducing visceral fat weight
08/08/2012EP2484358A1 Agent for inhibiting decrease of visceral fat in patient with parkinson's disease
08/08/2012EP2483308A1 Drug fusions and conjugates with extended half life
08/08/2012EP2483300A1 Synthetic myostatin peptide antagonists
08/08/2012EP2483298A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 1298